Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.
Claes M. Gustafsson(University of Gothenburg), Lars-Åke Marké(St. Marien Hospital), M. Britton(St. Marien Hospital), Bo Norrving(Lund University), Kjell Asplund(Umeå University), Bertil Olsson(St. Marien Hospital)
Cited by 130
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Priority actions for the non-communicable disease crisis
|The Lancet|2011|1.6k
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
|The Lancet Neurology|2023|731
Action Plan for Stroke in Europe 2018–2030
|European Stroke Journal|2018|616